Influencing Public Policy on Research and Clinical Endocrinology

Society Letters

The Endocrine Society produces and signs onto a range of letters to elected officials, Federal agencies, and other legislative and deliberative bodies.   

  • Letter to Secretary Azar to Present Comprehensive Budget Requests for Children and Families at the Border 
    October 4, 2018 | The Endocrine Society joined 110 other members of the Coalition for Health Funding in a letter to Secretary Azar regarding the use of transfers to care for unaccompanied migrant children and the need for a budget request to adequately address this crisis.
  • 2019 Coalition Letter on Fetal Tissue Research
    September 10, 2018 | Coalition letter supporting continued federal funding of fetal tissue research, conducted in accordance with current federal rules.
  • ES-ATA-AACE Sign-on Letter Opposing CMS FNA Proposal
    September 7, 2018 | The Endocrine Society, along with the American Association of Clinical Endocrinologists, and the American Thyroid Association submitted a comment letter that opposes a recent proposal by CMS to cut payments for fine-needle aspiration codes, which would negatively impact endocrinologists.
  • Endocrine Society Comments on Competitive Bidding Program
    September 10, 2018 | This comment letter addresses concerns with the Competitive Bidding Program and its impact on the ability for patients with diabetes to access high-quality durable medical equipment and other supplies needed to manage their disease.
  • 2019 Medicare Physician Fee Schedule Comments
    September 4, 2018 |The Endocrine Society provided comments to CMS on currently proposed revisions to payment policies under the Medicare Physician Fee Schedule for 2019 that would affect Endocrine Society members.
  • Exclusion of Gender Alterations from the Medical Benefits Package
    September 4, 2018 | The Endocrine Society submitted comments to the Department of Veterans Administration’s request for information related to gender alteration surgeries.
  • Cognitive Care Alliance Comments on CMS Payment Proposal
    August 31, 2018 | The comment letter opposes a proposal by the Centers for Medicare and Medicaid Services to condense the evaluation and management codes. The proposal would be detrimental to reimbursement for endocrinologists, who primarily bill levels 4 and 5.
  • Cognitive Specialty Coalition Sign-on Letter Opposing E/M Proposal
    August 28, 2018 | This comment letter opposes a proposal by the Centers for Medicare and Medicaid Services that would collapse existing evaluation and management codes.
  • Sign-on Letter Opposing CMS Proposal on Evaluation and Management Services
    August 27, 2018 | The sign-on letter opposes a proposal included in the 2019 Medicare Physician Fee Schedule that would negatively impact physicians who predominately bill evaluation and management services. The letter opposes the implementation of this proposal and asks CMS to review other methods for redefining and valuing these services.
  • Coalition Support Letter to Senate Sponsors of Osteoporosis Bill
    August 23, 2018 | The Endocrine Society joined with other organizations thanks Senate sponsors of the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2018.
  • Comments on Guiding Principles to Apply to Systematic Review in TSCA
    August 16, 2018 | In these letters, the Endocrine Society writes to the EPA and joins others in encouraging the adoption of systematic review approaches in the evaluation of chemicals under the new Toxic Substances Control Act. We also ask EPA to be more specific and transparent in explaining how they will evaluate scientific research for potential harmful effects of chemicals and recommended that EPA develop clearly-defined criteria for expert reviewers, including explicit policies governing conflicts of interest.
  • Friends of NIEHS Sign-on Letter Supporting the Superfund Research Program
    August 6, 2018 | Letter to the House and Senate Interior-Environment conferees in support of $80 million for the National Institute of Environmental Health Sciences Superfund Research Program.
  • Sign-on Letter Opposing EPA Policy Directive Regarding Membership of EPA Federal Advisory Committees
    August 6, 2018 | A joint letter from public-health, science, conservation, and higher-education organizations urges Acting EPA Administrator Andrew Wheeler to rescind the policy directive issued by former EPA Administrator Scott Pruitt on October 31, 2017, which barred scientists who conduct EPA-funded research from serving on EPA federal advisory committees.
  • Diabetes Advocacy Alliance Comments on USPSTF Research Plan on Abnormal Blood Glucose
    August 1, 2018 |The Endocrine Society and members of the Diabetes Advocacy Alliance submitted comments to the U.S. Preventive Services Task Force on its draft research plan to address abnormal blood glucose in Type 2 Diabetes. The comments request the addition of systematic reviews, studies in community-based settings, and interventions for diabetes self-management education and support, among other items, in the research plan.
  • Endocrine Society Comments on Proposed Title X Changes
    July 31, 2018 | The Endocrine Society submitted a letter to Secretary of Health and Human Services Alex Azar to comment on the proposed changes to the Title X funding program which would affect access to care and funding for contraceptive and preventive services for women.
  • Endocrine Society Comments on European Commission Proposal for Revised EU EDC Strategy
    July 18, 2018 | The Endocrine Society encouraged the development of a comprehensive EU strategy on EDCs and issued recommendations for specific topics that should be addressed in the strategy.
  • Endocrine Society Supports the Access to Infertility Treatment and Care Act
    July 5, 2018 | Unfortunately, many insurance plans do not offer coverage for infertility treatments, cryopreservation, or adoption, leaving those affected to pay the high costs of treatments and/or adoption out-of-pocket. This legislation builds upon existing laws and ensures that all Americans who need and want infertility treatment services have access to them.
  • Joint Letter Addressing Insulin Pump Denials without Part B Claims
    June 20, 2018 | The Endocrine Society, JDRF, AACE, and ADA submitted a letter to Noridian regarding hundreds of denials for insulin pumps when a Part B claim is not present. There are numerous reasons why a Part B claim may exist at the time a pump rental claim is filed and we urge the carrier to reverse the policy which denies these claims.
  • Endocrine Society Opposes the Use of Prevention and Public Health Funds to Offset Spending in the Puerto Rico Economic Empowerment Act
    June 18, 2018 | The Endocrine Society joined 65 other groups in signing a letter addressed to Senators Marco Rubio and Orrin Hatch to express opposition to using Prevention and Public Health Funds for purposes unintended under the original authorization. The Endocrine Society recognizes the need to provide economic support to Puerto Rico in the aftermath of last year's devastating hurricane season, but does not believe it should come at the expense of critical public health funding.
  • Endocrine Society Expresses Concerns Over Resolution Limiting Surgeries in Infants with DSD
    June 15, 2018 | The Endocrine Society and the Pediatric Endocrine Society co-wrote a letter to California state Senators Scott Wiener, Steve Glazer, and Monique Limón expressing concerns over resolution SCR-110 that would restrict parents’ rights to make decisions regarding surgery for infants born with Differences in Sex Development. Our organizations believe that nuanced, scientific, and evidence-based decision making that is currently part of the process is not reflected in the bill, and therefore does not adequately address the needs of constituencies.
  • Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): June 12, 2018 | Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) requests $39.3 billion for the National Institutes of Health for fiscal year 2019, with a proportional increase in funding for a total of $1.531 billion for NICHD.
  • Endocrine Society Concerned Proposed EPA Transparency Rule Will Restrict Ability to Develop and Implement Effective Restrictions on Hazardous Chemicals
    May 21, 2018 | While the Endocrine Society supports appropriate public access to data and methodology for independent validation, the proposed rule is unclear and difficult to describe operationally. We are therefore concerned that the proposed regulation will restrict the ability of the EPA to develop and implement effective restrictions on hazardous chemicals. As such, this rule would increase the potential for human health harms due to chemical exposures.
  • Endocrine Society Opposes Proposed Change to National Crime Victimization Survey Related to Gender Identity
    May 11, 2018 | The notice proposes to raise the minimum age at which National Crime Victimization Survey questions are administered on sexual orientation and gender identity from age 16 to 18. The Endocrine Society is concerned that the proposed changes to information collection will result in the loss of data on an important subset of the transgender community and provide an incomplete picture of crimes committed against this population. We urge the Administration to continue to collect information on gender identity and sexual orientation from individuals 16 years of age and older.
  • Endocrine Society Supports J Code for Growth Hormone Stimulation Testing Agent MACRILEN
    Mary 10, 2018 | The Society sent a letter to the Centers for Medicare and Medicaid Services (CMS), showing support for their proposal to develop a J Code for MACRILEN. The FDA-approved oral agent can diagnose Adult Growth Hormone Deficiency (AGHD) without an injection.
  • Endocrine Society Recommends Removal of Medication-Related Products from Tariffs Proposed Rule
    May 9, 2018 | The Endocrine Society opposes the application of an additional 25 percent tariff on medications, raw materials used in the production of medications, and medical devices. The Society is concerned that additional tariffs will lead to a shortage of medications as the manufacturers identify alternative sources that are less expensive or an increase in price that could make the cost untenable.
  • Endocrine Society Identifies Improvements to EPA's Strategic Plan to Promote Alternative Test Methods
    April 26, 2018 | The Society recommends that that the alternative methods evaluated by the EPA should be able to predict effects on the endocrine system in a rigorous, transparent manner that avoids conflicts of interest. We also recommend that alternative methods should include academic research and academic scientists, and that time frames and goals should be realistic.
  • Friends of NIEHS Sign-On Letter in Support of the Superfund Research Program
    April 18, 2018 | This letter requests an increase to the Superfund Research Program appropriation of $3 million in the Interior and Environment Appropriations Bill for fiscal year 2019 to a total of $80 million. The letter was organized by the Friends of the National Institute of Environmental Health Sciences.

See all...

Society Testimony

Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.

See all...